Skip to main content

2025 Impact

Exceeding expectations! The Lobo Cancer Challenge was celebrated at University Stadium on September 20, 2025.

1,940 Challengers in 77 teams along with 79 Sponsors:
together we raised $683,182 to #UniteAgainstCancer in New Mexico!

Thank you to everyone for your contribution — Challengers, Sponsors, Volunteers, Donors — and to our community for your amazing support.

TOP FUNDRAISING AREAS:

$40,791

Children’s Cancer Research Fund

$40,675

Leukemia, Lymphoma, Myeloma and Stem Cell Transplantation

$33,126

Women’s Cancer Research (gynecologic cancers)

$31,184

Adolescent and Young Adult Cancers (AYA) Research

$27,697

General Research Fund

$27,490

Breast Cancer Research

$22,815

Prostate, Renal, Bladder and Testicular Cancers Research

$21,201

Patient Assistance Fund

$14,820

Skin Cancer Fund

$12,321

Neuro-Oncology Cancers

$8,740

Polly Rogers Pancreatic Cancer Fund

$6,470

Gastrointestinal Cancer Research

Head & Neck Cancers Research received $3,895 and the Lung Cancers Prevention, Research and Treatment Fund received $3,770. The Cancer Palliative / End of Life Care Fund received $3,070 and the Training and Education of Cancer Health Professionals received $2,675. The Cancer Survivorship Clinic received $1,940 and the New Mexico Best Health Fund received $1,640. The Early Phase Cancer Clinical Trials Program received $1,101 and Sarcomas and Bone Cancers Research received $410.

 

Every dollar raised by our Challengers went directly to the cancer fund of their choice at the UNM Comprehensive Cancer Center.

Learn more about each program on the Programs for Donation page. Most program descriptions include a link to their department web pages on the UNM Comprehensive Cancer Center website.

 


 

 

Connect with us

YouTube icon

TikTok icon - no bg


Presented By
Blake's Lotaburger logo

If you continue to use this site, you consent to use all cookies. We use cookies to offer you a better browsing experience. Read how we use cookies and how you can control them by visiting our Privacy Policy.

If you continue to use this site, you consent to use all cookies.